Total Liabilities: The total value of all possible claims against the corporation.
Supernus Pharmaceuticals, Inc. (SUPN) had Total Liabilities of $390.93M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$211.57M |
|
$-4.11M |
|
$23.01M |
|
$188.56M |
|
$215.51M |
|
$-3.94M |
|
$2.02M |
|
$-1.91M |
|
$-1.91M |
|
$-4.11M |
|
$-4.11M |
|
$-4.11M |
|
$-4.11M |
|
$-3.94M |
|
$21.58M |
|
56.45M |
|
56.45M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$644.18M |
|
$10.53M |
|
$808.47M |
|
$1.45B |
|
$338.17M |
|
-- |
|
$52.76M |
|
|
Total Liabilities |
$390.93M |
$1.06B |
|
$367.38M |
|
$1.06B |
|
57.46M |
|
| Cash Flow Statement Financials | |
$47.33M |
|
$4.11M |
|
$9.13M |
|
$69.33M |
|
$129.90M |
|
$60.57M |
|
$33.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.13% |
|
-1.86% |
|
-1.86% |
|
-- |
|
-0.90% |
|
-1.94% |
|
$45.99M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.28 |
|
1.13 |
|
79.89 |
|
-0.39% |
|
-1.12% |
|
-0.28% |
|
-0.39% |
|
$18.48 |
|
$0.81 |
|
$0.84 |
|